Is This Healthcare Stock a Millionaire Maker?
View original at fool.comMotley Fool - Stock Analysis Title: Is This Healthcare Stock a Millionaire Maker?…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
It's an incredibly high bar to expect Axsome Therapeutics to match the performance it has had since 2015, when it started as a significantly smaller biotech stock
60% confidenceIt's unlikely that Axsome can pull off a similar performance through the next decade, as it would give the company a market cap of about $157 billion, making it one of the largest drugmakers in the world
60% confidenceAxsome Therapeutics still has a deep pipeline and plenty of catalysts ahead
60% confidenceThe company still has a deep pipeline and plenty of catalysts ahead
60% confidenceAxsome Therapeutics has delivered market-beating returns since IPO thanks to significant clinical and regulatory progress, as well as a portfolio of now-approved drugs that generate solid sales
60% confidenceAxsome Therapeutics matching its historical performance would require achieving a market cap of about $157 billion, making it one of the largest drugmakers in the world, which is unlikely but not impossible
60% confidenceIf you had invested $50,000 into Axsome Therapeutics following its IPO, you would be sitting on close to $1 million today, given its compound annual growth rate of 33.32% over this period
60% confidenceAxsome Therapeutics has delivered market-beating returns thanks to significant clinical and regulatory progress, as well as a portfolio of now-approved drugs that generate solid sales
60% confidenceIf you had invested $50,000 into Axsome Therapeutics following its IPO, you would be sitting on close to $1 million today, given its compound annual growth rate of 33.32% over this period
60% confidence